Savara
SVRA
78 hedge funds and large institutions have $92.7M invested in Savara in 2019 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 22 closing their positions.
14% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 22
13.54% more ownership
Funds ownership: 36.85% → 50.39% (+14%)
4% more funds holding
Funds holding: 75 → 78 (+3)
6% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 18
0% more capital inflows, than outflows
Capital inflows: $13.3M | Capital outflows: $13.2M
35% less call options, than puts
Call options by funds: $146K | Put options by funds: $224K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$6.17M |
| 2 |
EcoR1 Capital
San Francisco,
California
|
+$1.72M |
| 3 |
Farallon Capital Management
San Francisco,
California
|
+$1.58M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.07M |
| 5 |
Pura Vida Investments
New York
|
+$346K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Consonance Capital Management
New York
|
-$4.16M |
| 2 |
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.88M |
| 3 |
Sofinnova Investments
Menlo Park,
California
|
-$1.4M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$1.08M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$916K |
SVRA Hedge Fund Activity: Q4 2019 in Review
78 of the 5,095 institutional investors tracked by Wall St. Rank reported a position in Savara (SVRA) for Q4 2019, worth a combined $92.7M — up 130% from $40.2M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new SVRA positions and 22 closed out — a net gain of 3 holders — while 19 added to existing stakes and 18 trimmed.
The largest buyer was Bain Capital Life Sciences Investors, opening a new position worth an estimated $6.17M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $4.16M sold.
- 78 institutional investors held Savara (SVRA) as of Q4 2019, up from 75 in Q3 2019.
- Funds reported $92.7M of Savara stock for Q4 2019, up 130% quarter-over-quarter.
- 25 funds opened new Savara positions in Q4 2019 and 22 closed out, a net change of +3 holders.
- The largest Savara buyer in Q4 2019 was Bain Capital Life Sciences Investors, an estimated $6.17M added.
- The largest Savara seller in Q4 2019 was Consonance Capital Management, an estimated $4.16M sold.
Based on aggregated 13F filings for Q4 2019.